Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
H2O America HTO Stock Valuation H2O America posts 58 EPS miss trailing Street consensus estimates Ferroglobe PLC GSM shares surge 28 as investors overlook Q1 loss revenue decline EDAP EDAP TMS SA American Depositary Shares posts far wider Q4 2025 loss than estimates shares fall 279 today FRHC Freedom Holding drops 982 after Q1 2026 earnings release with no published analyst consensus estimates Edison International EIX Posts Q1 2026 TopandBottom Line Beats Amid Broader Utility Sector Momentum Dow Inc DOW Positioned for Upside Amid Global Natural Gas Supply Divergence How Yunhong YHGJ cash generation compares to earnings Mortgage Rates Remain Elevated as Bond Market Awaits Clearer Signals SK Hynix and Micron Join 1 Trillion Club as AI Resurgence Drives Semiconductor Surge FICO Mounts Defense Against Rising VantageScore Competition Walmart Inc Prepares to Release Q1 2027 Earnings Call Summary Krispy Kremes 16 Million Data Breach Settlement Deadline Approaches Government to Offload Up to 2 Stake in Coal India via Offer for Sale at Rs 412Share Floor Price California Water Service Group CWT Q1 2026 Earnings EPS Misses Estimates by 705 Amid Cost Pressures STTK Q1 2026 Earnings Shattuck Labs Reports Narrower Loss Beats EPS Estimates AVX Q1 2026 Earnings Narrow Loss Reported Amid Limited Financial Disclosure WFG Q1 2026 Earnings Hefty EPS Surprise Signals Resilience Amid Weak Timber Markets Essential Utilities Inc WTRG Q1 2026 Earnings EPS Miss Overshadows Mixed Utility Demand Coffee Holding Co Inc JVA Q4 2019 Earnings EPS Misses Estimates by Wide Margin Amid Ongoing Industry Challenges Acme United Corporation ACU Edges Lower as It Tests Support Zone Zimmer Biomet ZBH Loses Ground as Stock Nears Key Support Level Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus Camtek Shares Surge 3 as Momentum Builds Toward Key Resistance Maze Therapeutics MAZE Holds Steady Near Resistance as Consolidation Continues